PBMs Dodge Bullet in New CMS Rule—But Remain in Washington’s Crosshairs

Drug Industry Daily
A A
Pharmacy benefits managers breathed a sigh of relief last week when the Trump administration backed off proposals that would set Medicare drug prices based on the discounts offered by the benefits managers.

To View This Article:

Login

Subscribe To Drug Industry Daily